Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Ha

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Prostate Cancer and Prostatic Diseases|December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Todd Yezefski, et al.
NPJ Precision Oncology|April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancerDavid D Chen, Anat Zimmer, David D Yang, et al.
JCI Insight|May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsyBrian R Winters, Navonil De Sarkar, Sonali Arora, et al.
British Journal of Cancer|March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer|August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
JCI Insight|December 8, 2021
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancerNavonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
Leukemia|May 12, 2018
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencingGuangwu Guo, Noopur S Raje, Charles Seifer, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Prostate Cancer and Prostatic Diseases|December 23, 2022
Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancerMichael T Schweizer, Roman Gulati, Todd Yezefski, et al.
NPJ Precision Oncology|April 28, 2026
Multi-modal circulating cell-free DNA profiling to predict response to docetaxel in metastatic castration-resistant prostate cancerDavid D Chen, Anat Zimmer, David D Yang, et al.
JCI Insight|May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsyBrian R Winters, Navonil De Sarkar, Sonali Arora, et al.
British Journal of Cancer|March 19, 2019
Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
British Journal of Cancer|August 23, 2018
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology GroupDavid S Shulman, Kelly Klega, Alma Imamovic-Tuco, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
JCI Insight|December 8, 2021
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancerNavonil De Sarkar, Sayan Dasgupta, Payel Chatterjee, et al.
JCI Insight|November 3, 2018
Tumor fraction in cell-free DNA as a biomarker in prostate cancerAtish D Choudhury, Lillian Werner, Edoardo Francini, et al.
The Journal of Pathology|June 20, 2013
Distinct evolutionary trajectories of primary high-grade serous ovarian cancers revealed through spatial mutational profilingAli Bashashati, Gavin Ha, Alicia Tone, et al.
Leukemia|May 12, 2018
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencingGuangwu Guo, Noopur S Raje, Charles Seifer, et al.
Pageof 10